Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Regimen 1 Conivaptan QD	20
Overall Study	STARTED	Regimen 2 Conivaptan BID	20
Overall Study	STARTED	Regimen 3 Placebo	10
Overall Study	Full Analysis Set / Safety Analysis Set	Regimen 1 Conivaptan QD	20
Overall Study	Full Analysis Set / Safety Analysis Set	Regimen 2 Conivaptan BID	20
Overall Study	Full Analysis Set / Safety Analysis Set	Regimen 3 Placebo	9
Overall Study	End of Treatment	Regimen 1 Conivaptan QD	18
Overall Study	End of Treatment	Regimen 2 Conivaptan BID	16
Overall Study	End of Treatment	Regimen 3 Placebo	8
Overall Study	COMPLETED	Regimen 1 Conivaptan QD	16
Overall Study	COMPLETED	Regimen 2 Conivaptan BID	15
Overall Study	COMPLETED	Regimen 3 Placebo	8
Overall Study	NOT COMPLETED	Regimen 1 Conivaptan QD	4
Overall Study	NOT COMPLETED	Regimen 2 Conivaptan BID	5
Overall Study	NOT COMPLETED	Regimen 3 Placebo	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00478192/flow